Ombitasvir/Paritaprevir/R, Dasabuvir, and Sofosbuvir Treatment of Patients with HCV Genotype-Infection who Failed a Prior Course of DAA Therapy: The Quartz-I Study
Poordad, F, Bennett, M, Sepe, T.E, Cohen, E, Reindollar, R.W, Everson, G, Phillips, R.W, Siddique, A, Sullivan, J.G, Box, T.D, Fu, B, Pilot-Matias, T, Abunimeh, M, Cohen, D.E, Younes, Z
Published in Journal of hepatology (2016)
Published in Journal of hepatology (2016)
Get full text
Journal Article
1192 HIGH SUSTAINED VIROLOGICAL RESPONSE RATES WITH RESPONSE-GUIDED DANOPREVIR PLUS PEGINTERFERON ALFA-2A (40KD) AND RIBAVIRIN IN TREATMENT-NAIVE, HCV GENOTYPE 1 PATIENTS: ATLAS STUDY FINAL RESULTS
Marcellin, P, Cooper, C, Balart, L.A, Larrey, D.G, Box, T.D, Yoshida, E, Lawitz, E, Buggisch, P, Ferenci, P, Weltman, M, Labriola-Tompkins, E, Le Pogam, S, Nájera, I, Thomas, D.N, Hooper, G, Shulman, N, Zhang, Y, Navarro, M.T, Lim, C.Y, Brunda, M, Yetzer, E.S, Terrault, N
Published in Journal of hepatology (01.04.2012)
Published in Journal of hepatology (01.04.2012)
Get full text
Journal Article
SAT-156 - Ombitasvir/Paritaprevir/R, Dasabuvir, and Sofosbuvir Treatment of Patients with HCV Genotype-Infection who Failed a Prior Course of DAA Therapy: The Quartz-I Study
Poordad, F., Bennett, M., Sepe, T.E., Cohen, E., Reindollar, R.W., Everson, G., Phillips, R.W., Siddique, A., Sullivan, J.G., Box, T.D., Fu, B., Pilot-Matias, T., Abunimeh, M., Cohen, D.E., Younes, Z.
Published in Journal of hepatology (2016)
Published in Journal of hepatology (2016)
Get full text
Journal Article